Outcome Sciences, Inc. (OUTCOME), the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, announced that Nancy Dreyer, MPH, PhD, Chief of Scientific Affairs and Senior Vice President at Outcome, will be presenting at the International Society for Pharmacoepidemiology's (ISPE) 25th Anniversary International Conference on Pharmacoepidemiology and Therapeutic Risk Management. The conference is being held from August 16-19 at the Rhode Island Convention Center in Providence, Rhode Island.

The first session, entitled "Can Registries Deliver? The Methods and Use of Registries for Biologics", will be held on Monday, August 17th at 3:30 P.M. and will focus on the unusual challenges in studying the safety and effectiveness of biologics, and how registries are being used to generate evidence. Panelists will discuss design issues, considerations for interpreting data from biologics registries, and the regulatory perspective on risk management.

On Tuesday, August 18th at 2:45 P.M., Dr. Dreyer will participate in the case study discussion "Human Avian Influenza: Development of a Shoe-Leather Approach to Evaluating Treatment Effectiveness." This successful case study highlights a global initiative to study clinical presentation, natural history, treatment effectiveness and clinical outcomes for human avian influenza. The participants will present an old-fashioned approach to building collaboration, country by country, along with the study's learned lessons and potential applicability to other pandemic threats.

Dr. Dreyer's final presentation, "Developing Good Practice Guidance for Non-Randomized Studies of Comparativeness Effectiveness: A Workshop on Quality and Transparency", will take place at 4:00 P.M. on Tuesday, August 18th. This workshop will address the study of comparative effectiveness using observational studies. Panelists will present an overview of comparative effectiveness, describe on-going guidance activities from a U.S. government perspective, and present the GRACE Principles for review and discussion. The GRACE principles are the product of a broad initiative intended to provide high-level guidance to reviewers seeking to evaluate observational studies of comparative effectiveness and distinguish high-quality work. Learn more about the GRACE principles at graceprinciples.

For additional information on 25th Anniversary International Conference of Pharmacoepidemiology and Therapeutic Risk Management taking place on August 16-19, 2009, please go to: https://www.pharmacoepi/meetings/25thconf/index.cfm. Outcome is also exhibiting at the conference and is located at booth #1.

About the International Society for Pharmacoepidemiology (ISPE)

ISPE is an international organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy; education; and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, and therapeutic risk management.

Additional information on ISPE can be found on the ISPE website at https://www.pharmacoepi/

Source
Outcome